News

Biocair partners with TrakCel to improve visibility in the supply chain

Experienced life sciences logistics company, Biocair, has partnered with TrakCel and integrated their systems with OCELLOS to improve customer service, automation and visibility in the cell and gene therapy supply chain.

OCELLOS by TrakCel is an integrated cell orchestration solution designed to manage and streamline the cell, gene and immunotherapy supply chain. The platform ensures tracking of both chain of identity and chain of custody, both vital parts of the patient journey, to support the scalability of cell and gene therapy development.

BioIVT to Host an Advanced In Vitro ADME Strategies Symposium in Copenhagen

Presenters will discuss the ICH M12 Drug Interaction Studies Guideline, and novel ADME models and methodologies

BioIVT, a leading provider of biospecimens and ADME-Tox research products and services for drug and diagnostic development, today announced that it will be hosting an Advanced In Vitro ADME Strategies Symposium at the Scandic CPH Strandpark Hotel in Copenhagen, Denmark on June 9.

‘UK science powerhouse’ opens its doors

Across the city, leading science companies and innovation parks will open their doors to showcase the cluster’s contribution to STEM innovation in the UK and strengthen its diverse, equitable and inclusive community.

CN Bio appoints Dr. Samantha Macro as Chief Financial Officer

Key executive appointment provides extensive financial industry experience as the Company implements ambitious global growth strategy

Nottingham CRO bolsters pharmacology expertise with appointment of Chief Scientific Officer

Nottingham-based Contract Research Organisation (CRO) Cellomatics Biosciences has announced the appointment of Professor David Lambert, FRCA and FFPMRCA as Chief Scientific Officer (CSO).

Based in Nottingham, Cellomatics is a specialist preclinical CRO with expertise in five main therapeutic areas: oncology, immuno-oncology, immunology, inflammation and respiratory. Founded in 2015, Cellomatics has since positioned itself as the CRO of choice for its growing global client base seeking expert support with the development of bespoke bioassays.

Innovative, fully defined hydrogel sets new benchmark in 3D Cell Culture.

AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results.

People Pathways May Issue

Check out this month's People Pathways newsletter where you can read about:

New event launched - 'Agile' Working for Productivity and Growth

Experience the ‘Agile’ way of thinking in this practical taster session and find out how Agile project management can boost efficiency, help reduce costs and promote continuous improvement. The session is planned for Thursday July 6 at St John's Innovation Centre, Cambridge.

Qualified Scrum Master and Scrum Coach from Hethel Innovation, Sam Payne, will lead you through the basic principles of ‘Agile’ project management to give you an insight into the Agile approach to achieving your business goals.

SRG Global STEM Salary Survey 2023

Attracting and retaining talent in STEM is business critical.

According to almost three-quarters of global senior leaders, talent and skills shortages are the greatest barrier to business strategy over the next 12 months.

In this competitive and skills-short market, understanding current salary levels can unlock better recruitment outcomes faster to help you retain, and attract the most skilled talent.

Kadans continues Oxford expansion with Windrush Innovation Centre purchase

Kadans Science Partner will add Windrush Innovation Centre in Oxford, UK to its Pan-European portfolio. The asset will be freehold acquired from Tozi Limited. Kadans intends to demolish the existing building and create over 60,000 sq ft of new high specification laboratory and office space in partnership with the tenant, Oxford Biomedica.

My Account